CAMKK2 and Alzheimer disease: Interestingly, a recent study conducted immunohistochemical analysis on three serial sections from the frontal cortex (Brodmann areas 11 and 12) of three AD patients and three CN individuals, reporting no significant difference in the percentage of CAMKK2-positive neurons between the groups (Gaff et al., 2021).